About Vidara
Pharma

We are passionate about supporting the local pharma industries with high-quality products for the markets. Our track record in product development and collaborations with global entities reflects our dedication.​

Our portfolio solutions are fueled by our collaborations. We are constantly working to amplify these partnerships to the benefit of our customers. To learn more about our partnerships, click here.​

We are your Reference Partner in the Pharma industry, as we are inspired by making our customers and partners successful and always trust in ourselves to offer the best solutions for your needs, constantly.​​

Know more about us

Rectangle_29

Portfolio Solutions

home_portfolio_new
PHARMA EMEA

We co-develop and distribute APIs, excipients and materials for the EMEA markets through our office in Lisbon (Portugal)

Headerimage_Vidara_Americas
PHARMA MÉXICO

We distribute APIs, excipients and materials for the Mexican markets through our office in Mexico City

Achievements

2025

Our company has been acquired by Vidara, thereby becoming part of the Vidara organization and adopting the new corporate name Vidara Pharma.

2022

API Co-development​ with Chr. Olesen Synthesis for the development and​ manufacturing of Apomorphine

2021

API Co-development, manufacturing and distribution of Octenidine with Lebsa​​

2020

Launch of customer portal for Ingredients & Materials Europe

2017

Ingredients & Materials Americas activities start​​​

2016

CAEM Certification for sales of organic products​

2008

Our company becomes the CEP holder for Heparin Sodium, produced at Changzhou Quianhong Bio Pharma Co.

2007

Exclusive distribution agreement with CSPC Weisheng Ph. Co Ltd. for distribution of pharma grade Ascorbid Acid and derivatives​​​

1973

Foundation of our company start with trading of Active Pharmaceutical Ingredients (API)​​​